Registration of Patent Term Extension (Pharmaceuticals and Medical Devices)
(Conclusion)
Patent Term Extension is admitted.
The content of the Disposition was recognized to be different from the content of the “active ingredient” in the written approval, and the patent term extension was approved.
*In another case, the same patent was judged to be noninfringing. (Tokyo District Court 2018 (Wa) 38504)
*These decisions are not necessarily inconsistent because when arguing patent term extension, the “active ingredient” is the subject of patent term
<Writer: Hideki Takaishi (Attorney-at-law licensed in Japan and California)>
https://www.ip.courts.go.jp/app/files/hanrei_en/947/002947.pdf